The Centre for Bioengineering and Biotechnology is a catalyst for advancing bioengineering and biotechnology research and innovation through industry collaborations and partnerships.
More than 150 faculty members, from every faculty on campus, are actively engaged with the centre, working in collaboration to provide a resource of varying expertise.
Our mandate is to build healthy, active partnerships between centre researchers and corporate members through collaborative projects, mutual interest building, and networking events.
To learn more about partnerships, please email us.
Vision:
The Centre for Bioengineering & Biotechnology (CBB) enables interdisciplinary research across the university to address global challenges in human health and help translate those research results rapidly into practice, policy and impactful health outcomes. Achieving this vision will help the University of Waterloo to cement an international reputation at the interface of technology and human health.
Mission:
To achieve this vision, CBB's mission is to:
- Enable knowledge translation and support of the interdisciplinary research community through seminars, networking opportunities, and support of student groups
- Be a conduit to Waterloo's ecosystem of unique health related R&D and clinical resources
- Cultivate relationships with key stakeholders in technology, human, animal and environmental health and practice including industry, hospitals, community, and international bodies
- Provide Project Coordination/Management for large/inter-institutional projects
Join us:
To become a member of CBB, you can start by filling out a quick survey. We will then be in touch to discuss further.
News
Advancing Healthcare through Innovative Technology
Advancing healthcare through innovative technology
Medical devices can be used to diagnose or prevent disease, they can improve a patient’s quality of life and they often save lives. Devices such as pacemakers have been around since the late 1950s, but advancements in med-tech have come a long way since then. As research expands and technology advances, a multitude of medical devices are being developed and prepared for market.
CBB members Jennifer Boger and Mathieu Doucet design new framework that aims to avoid unintentional consequences of technology
We have an intimate relationship with technology. It is infused in our daily life, from our home and car to our finances and health care. As we welcome new technologies into our most personal spaces, there is a growing recognition that design-based thinking needs to consider ethics and the users it serves.